Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
1998-8-5
|
pubmed:abstractText |
Childhood supraventricular tachycardia (SVT) carries a good prognosis. Thus, treatment should be based on the use of drugs with a low risk of such potentially serious side effects as proarrhythmia, which is well documented for class I and III drugs in children. We studied all pediatric patients with a first manifestation of SVT between 1988 and the end of 1995 who were seen for a follow-up examination, including Holter monitoring, during 1996. The minimum follow-up period was 12 months. Fifty children met study entry criteria. Mean patient age at first presentation was 2 years (median 1 month), with 33 of the patients (66%) having experienced their first episode of tachycardia in their first year of life. Of 39 patients initially treated with either digoxin or a beta blocker, SVT in 29 (75%) responded favorably to this treatment. There were no adverse effects. Of the 10 children whose disease did not respond to these first-line agents, 9 (23% of those treated) required class I or III antiarrhythmic drugs. Thus, first-line antiarrhythmic long-term prophylaxis using drugs with a favorable risk profile, such as digoxin and beta blockers, resulted in successful disease management in a large proportion of unselected children, avoiding the need for chronic use of class I or class III antiarrhythmic drugs.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
0002-9149
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
1
|
pubmed:volume |
82
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
72-5
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:9671012-Adolescent,
pubmed-meshheading:9671012-Adrenergic beta-Antagonists,
pubmed-meshheading:9671012-Anti-Arrhythmia Agents,
pubmed-meshheading:9671012-Child,
pubmed-meshheading:9671012-Child, Preschool,
pubmed-meshheading:9671012-Digoxin,
pubmed-meshheading:9671012-Female,
pubmed-meshheading:9671012-Humans,
pubmed-meshheading:9671012-Infant,
pubmed-meshheading:9671012-Infant, Newborn,
pubmed-meshheading:9671012-Male,
pubmed-meshheading:9671012-Tachycardia, Sinoatrial Nodal Reentry,
pubmed-meshheading:9671012-Treatment Outcome
|
pubmed:year |
1998
|
pubmed:articleTitle |
Results of a restrictive use of antiarrhythmic drugs in the chronic treatment of atrioventricular reentrant tachycardias in infancy and childhood.
|
pubmed:affiliation |
Division of Pediatric Cardiology, University Children's Hospital, Berne, Switzerland.
|
pubmed:publicationType |
Journal Article
|